Related Experiment Videos
Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project
1Department of Laboratory Medicine, School of Medicine, University of California, San Francisco 94143-0626.
Insights
Neonatal bilirubin levels show minimal impact on infant intelligence quotient (IQ), definite neurological issues, or hearing loss. Higher bilirubin levels correlate with minor motor abnormalities, though their clinical significance is limited.
Area of Science:
- Neonatalogy
- Neurodevelopmental Pediatrics
- Public Health
Background:
- Neonatal hyperbilirubinemia is common, and concerns exist regarding its potential long-term neurodevelopmental effects.
- Understanding the relationship between bilirubin levels and neurodevelopment is crucial for clinical management and parental counseling.
Purpose of the Study:
- To investigate the association between neonatal bilirubin levels and neurodevelopmental outcomes in infants.
- To assess the impact of neonatal jaundice on intelligence quotient (IQ), neurological examination, and hearing loss.
Main Methods:
- A prospective cohort study involving 41,324 infants across 12 US medical centers.
- Infants had birth weights of at least 2500g, recorded neonatal bilirubin levels, and were followed up to at least 1 year.
- Neurodevelopmental outcomes assessed included IQ at age 7, neurological examination at age 7, and sensorineural hearing loss at age 8.
Main Results:
- No significant association was found between neonatal bilirubin levels and IQ scores in children.
- While higher bilirubin levels showed a stepwise increase in abnormal or suspicious neurological examination results, this was primarily linked to minor motor abnormalities.
- Sensorineural hearing loss was not associated with elevated neonatal bilirubin levels.
Conclusions:
- Neonatal bilirubin levels appear to have a limited impact on cognitive function (IQ), major neurological deficits, and hearing.
- Higher bilirubin levels are associated with mild motor abnormalities, but the clinical relevance is questionable due to weak association and mild presentation.
Objective:
To examine the association between neonatal bilirubin levels and subsequent neurodevelopmental outcome.
Design:
Prospective cohort study.
Setting:
12 US medical centers from 1959 (first births) to 1974 (last follow-up).
Participants:
41,324 singleton white or black infants with birth weight > or = 2500 g who had neonatal bilirubin measurements recorded and survived at least 1 year.
Main Outcome Measures:
Wechsler Intelligence Scale for Children Intelligence Quotient (IQ) at age 7 years, blinded neurologic examination at age 7 years, and sensorineural hearing loss at age 8 years.
Results:
There was no association between IQ and bilirubin. For example, comparing children who had maximum bilirubin levels > or = 342 mumol/L (20 mg/dL) with those who had lower bilirubin levels, adjusted mean IQs were 105.0 and 103.4 in whites (difference + 1.6; 95% confidence interval [CI]: -0.4 to +3.5) and 91.0 and 93.3 in blacks (difference -2.3; 95% CI: -4.8 to +0.2). Abnormal neurologic examination results were reported in 12 of 268 children (4.5%) with bilirubin > or = 342 mumol/L (20 mg/dL) compared with 1249 of 33,004 children (3.8%) with lower levels (relative risk [RR] = 1.2; 95% CI: 0.7 to 2.1). The frequency of abnormal or suspicious neurologic examination results increased in a stepwise fashion with increasing bilirubin level (P < .001), from 4346/29,258 (14.9%) of those with bilirubin levels < 171 mumol/L (10 mg/dL) to 60/268 (22.4%) of those with bilirubin levels. > or = 342 mumol/L (20 mg/dL), apparently due to increasing minor motor abnormalities at higher bilirubin levels. Sensorineural hearing loss was not associated with high bilirubin levels (RR = 1.0; 95% CI: 0.3 to 3.0).
Conclusions:
Neonatal bilirubin levels seem to have little effect on IQ, definite neurologic abnormalities, or hearing loss. Higher bilirubin levels are associated with minor motor abnormalities, but the clinical importance of this finding is limited by the weakness of the association, the mild nature of the abnormalities, and the lack of evidence that they are prevented by treatment.